NCT03809130

Brief Summary

This trial studies how well Untire application intervention works in reducing cancer-related fatigue in cancer patients and survivors.The Untire application focuses on themes that have been identified as causing or contributing to cancer-related fatigue. It may provide information and tips to improve lifestyle, give exercises for body and mind to increase energy levels, offer weekly reports to measure progress, and offer access to an online support community.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
27

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 10, 2018

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

January 16, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 18, 2019

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 20, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 20, 2019

Completed
Last Updated

July 29, 2020

Status Verified

July 1, 2020

Enrollment Period

6 months

First QC Date

January 16, 2019

Last Update Submit

July 27, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in patient-reported fatigue severity as assessed with the Checklist Individual Strength (CIS) between T0 and T1

    The effect of the intervention on fatigue will be analyzed with a generalized linear model, including CIS-20 sum score at T1 as the dependent variable, CIS-20 sum score at T0 as covariate, and group (intervention versus wait-list control) as independent variable.

    Baseline up to 3 months

Secondary Outcomes (8)

  • Total days on which the patient logged in to the app

    Up to 6 months

  • Total number of activities completed on the app

    Up to 6 months

  • Total number of completed assessments on the app

    Up to 6 months

  • Change in negative affect (delta-NA) between T0-T1

    Baseline up to 3 months

  • Change in positive affect (delta (PA) between T0-T1

    Baseline up to 3 months

  • +3 more secondary outcomes

Study Arms (2)

Arm I (Untire application)

EXPERIMENTAL

Patients use Untire application intervention after baseline up to 6 months.

Other: Internet-Based InterventionOther: Quality-of-Life AssessmentOther: Questionnaire Administration

Arm II (Untire application)

ACTIVE COMPARATOR

Patients use Untire application intervention after 3 months up to 6 months.

Other: Internet-Based InterventionOther: Quality-of-Life AssessmentOther: Questionnaire Administration

Interventions

Use Untire application after baseline up to 6 months

Arm I (Untire application)

Ancillary studies

Also known as: Quality of Life Assessment
Arm I (Untire application)Arm II (Untire application)

Ancillary studies

Arm I (Untire application)Arm II (Untire application)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who present at the Cancer-Related Fatigue Clinic or the Psychiatric Oncology Clinic for an initial consult
  • Patients who speak and read English
  • Patients who are willing and able to review, understand, and provide written consent
  • Patients who agree to comply with all study procedures
  • Patients who are in possession of a smartphone or tablet that supports the Untire app software
  • Patients rating their current fatigue severity as moderate to severe (= or \> 4 on a 0-10 scale), assessed as part of the clinics' screening procedure

You may not qualify if:

  • Case report of diagnosis of a formal thought disorder (e.g., schizophrenia)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

M D Anderson Cancer Center

Houston, Texas, 77030, United States

Location

Related Links

MeSH Terms

Conditions

Neoplasms

Study Officials

  • Cobi J Heijnen

    M.D. Anderson Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 16, 2019

First Posted

January 18, 2019

Study Start

December 10, 2018

Primary Completion

June 20, 2019

Study Completion

June 20, 2019

Last Updated

July 29, 2020

Record last verified: 2020-07

Locations